Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,130 | -135,665 | -99,234 | -63,528 | -36,606 |
| Depreciation Amortization | 1,337 | 3,238 | 2,037 | 941 | 443 |
| Income taxes - deferred | N/A | -6,580 | -6,580 | -6,580 | N/A |
| Accounts receivable | -667 | -20,727 | -13,070 | -10,723 | -4,605 |
| Other Working Capital | -2,631 | -21,050 | -12,092 | -10,275 | -13,796 |
| Other Operating Activity | 13,317 | 60,648 | 43,073 | 30,324 | 14,895 |
| Operating Cash Flow | $-18,774 | $-120,136 | $-85,866 | $-59,841 | $-39,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,056 | 7,978 | -19,022 | 60,488 | 36,500 |
| PPE Investments | -41 | -278 | -36 | -17 | N/A |
| Purchase Sale Intangibles | -15,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -15,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $27,015 | $7,700 | $-19,058 | $60,471 | $36,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,870 | 114,639 | 112,942 | 25,206 | 18,861 |
| Other Financing Activity | -2,883 | -5,552 | -3,526 | -1,856 | -757 |
| Financing Cash Flow | $12,987 | $109,087 | $109,416 | $23,350 | $18,104 |
| Exchange Rate Effect | 188 | 12 | -73 | -52 | -3 |
| Beginning Cash Position | 128,003 | 131,340 | 131,340 | 131,340 | 131,340 |
| End Cash Position | 149,419 | 128,003 | 135,759 | 155,268 | 146,272 |
| Net Cash Flow | $21,416 | $-3,337 | $4,419 | $23,928 | $14,932 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,774 | -120,136 | -85,866 | -59,841 | -39,669 |
| Capital Expenditure | -41 | -278 | -36 | -17 | N/A |
| Free Cash Flow | -18,815 | -120,414 | -85,902 | -59,858 | -39,669 |